Top 10 Promising Stocks To Buy Right Now

Ever since the late 1950s, when commercial quantities of oil were first discovered in Nigeria's Niger Delta basin, West Africa has been an area of interest for oil and gas exploration and production companies. �

But a host of challenges, many of them related to threats of violence and corrupt political regimes, dissuaded many of the world's leading energy companies from prospecting areas of Africa more thoroughly.

However, that reluctance quickly changed to renewed optimism when Tullow Oil discovered the Jubilee oil field in Ghana back in 2007 ��a find hailed as one of the largest recent discoveries on the continent. Jubilee, which has an estimated reserve potential of about 5 billion barrels of oil, piqued the interest of a bevy of global exploration and production companies, who subsequently rushed into neighboring Gabon, Liberia, and Sierra Leone, eager to exploit the continent's vast natural resources. �

Energy companies exploring in Africa
Initially, it was mostly smaller, foreign exploration and production outfits, including Ophir Energy, Kosmos Energy, Africa Oil and others,�that dominated exploration off the coast of sub-Saharan Africa. Mid-sized international oil and gas companies, such as Anadarko (NYSE: APC  ) , which made an explosive move into exploring offshore Tanzania, where one of its deepwater exploration wells reported promising results last year, also played important roles.

Best New Companies To Invest In Right Now: BioMarin Pharmaceutical Inc.(BMRN)

BioMarin Pharmaceutical Inc. develops and commercializes biopharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and rest of the world. The company?s commercial products include Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase enzyme used for the treatment of mucopolysaccharidosis (MPS) VI; Kuvan, a proprietary synthetic oral form of 6R-BH4 used to treat patients with phenylketonuria (PKU), a metabolic disease; Aldurazyme used for the treatment of mucopolysaccharidosis I, a genetic disease; and Firdapse used to treat Lambert Eaton Myasthenic Syndrome, an autoimmune disease. It develops GALNS, an enzyme replacement therapy for the treatment of MPS IVA, a lysosomal storage disorder; PEG-PAL, an enzyme substitution therapy that is under Phase II clinical trial to treat PKU; BMN-673, a Phase I/II clinical trial product for the treatment of cancer; BMN-701, an enzyme replacement therapy, which is under Phase I/II clinical trials for Pompe disease, a glycogen storage disorder; and BMN-111, a peptide therapeutic that is under Phase I clinical trial for the treatment of achondroplasia. The company sells its Naglazyme, Kuvan, and Firdapse products to specialty pharmacies and end-users, such as hospitals and foreign government agencies, which act as retailers; and Naglazyme products to distributors and pharmaceutical wholesalers. It has a collaboration agreement with Genzyme Corporation for the manufacture of Aldurazyme; and an agreement with Merck Serono S.A. for the further development and commercialization of Kuvan and other products containing 6R-BH4 and PEG-PAL for PKU. BioMarin Pharmaceutical Inc. was founded in 1996 and is headquartered in Novato, California.

Advisors' Opinion:

• [By Monica Gerson]

  BioMarin Pharmaceutical (NASDAQ: BMRN) shares moved up 1.48% to $78.64. The volume of BioMarin Pharmaceutical shares traded was 966% higher than normal. BioMarin shares jumped on Roche Holding (OTC: RHHBY) takeover report..

Top 10 Promising Stocks To Buy Right Now: Ishares Xinhua China 25 (FXI)

iShares FTSE/Xinhua China 25 Index Fund (the Fund) seeks investment results that correspond generally to the price and yield performance of the FTSE/Xinhua China 25 Index (the Index). The Index is designed to represent the performance of the largest companies in the China equity market that are available to international investors. The Index consists of Class H and Red Chip shares of 25 of the largest and most liquid Chinese companies. Securities in the Index are weighted based on the total market value of their shares. Each security in the Index is a constituent of the FTSE All-World Index. All of the securities in the Index trade on the Hong Kong Stock Exchange.

The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. The Fund�� investment advisor is Barclays Global Fund Advisors.

Advisors' Opinion:

• [By Belinda Cao]

  The iShares China Large-Cap ETF (FXI), the largest Chinese exchange-traded fund in the U.S., climbed 0.6 percent last week to $38.43 in New York. The Standard & Poor�� 500 Index slipped 0.7 percent Sept. 20 for a weekly rally of 1.3 percent.

• [By Jonathan Yates]

  China recently announced a series of economic reforms that are very market driven. The main exchange traded fund for China,�iShares China Large-Cap�(NYSE: FXI), is up more than 10 percent for the last month of market action.

• [By Belinda Cao]

  The iShares FTSE China 25 Index Fund (FXI), the largest Chinese exchange-traded fund in the U.S., added 0.9 percent May 3 to $37.71, extending its weekly advance to 2.1 percent. The Standard & Poor�� 500 Index climbed 1.1 percent to 1,614.42, bringing its five-day rally to 2 percent.

• [By pamatlarge]

  As the Chinese economy slows down, investors can profit by shorting a long ETF that holds Chinese stocks in major industries. The iShares China Large-Cap ETF (FXI) has a market cap of $5.12 billion and is among the most heavily traded ETFs. The ETF concentrates its holdings in financial services, communication services and technology. The SPDR China ETF (GXC) is another large-cap ETF that is heavily invested in Chinese financial service companies and technology companies. The Morgan Stanley China A Share Fund (CAF) has a much smaller market cap of $474 million. This ETF invests in a broad range of industries including Chinese commercial banks, insurance companies and pharmaceutical companies. Holding a short position with these ETFs could pay off when one or more sections hits a downturn.

Top 10 Promising Stocks To Buy Right Now: Fleetmatics Group PLC (FLTX)

Fleetmatics Group PLC (FleetMatics), incorporated on October 28, 2004, is a provider of fleet management solutions delivered as software-as-a-service (SaaS). The Company offers Web-based and mobile application solutions, which provide fleet operators with visibility into vehicle location, fuel usage, speed and mileage and other insights into their mobile workforce. The Company offers fleet management software solutions. The Company�� FleetMatics-branded solutions sold under the FleetMatics or SageQuest names. Its solutions are accessed through a Web browser or mobile application and provide its customers with actionable business intelligence. Its SaaS offering consists of the easy-to-use components: Tracking Alerts, Route Replay, Geofencing and Landmarks, FleetTracking Dashboard, Fleet Reports, Mobile App, Speed Limits, Panoramic Reporting and Benchmarking. In addition to this core SaaS offering, it also offers the additional features to its customers: Fuel Card Reporting Integration, FleetMatics Fuel Card and Navigation Unit Integration. Effective August 8, 2013, Fleetmatics Group PLC a unit of Fleetmatics Investor Holdings LP, acquired Connect2Field Holdings Pty Ltd.

The Company�� Fleet Tracking Alerts allow fleet operators to set driver performance thresholds and receive e-mail notifications when unwanted driving behavior occurs. Notifications are sent when a vehicle enters or exits specified areas, moves during specified times, or when a vehicle�� speed or idle time exceeds specified thresholds. Its Route Replay feature allows customers to play back each journey taken by their vehicles, from start up to shut down and provides customers with minute-by-minute location and speed details. Fleet operators can start, stop, pause, and change the speed of the journey replay using intuitive playback controls to monitor and analyze driver behavior. Integration with Google Maps enables customers to pinpoint vehicle location with satellite, street views and zooming capabilities.

The Company�� Geofencing and Landmarks feature allows customers to designate areas on the map, in which vehicles are allowed or not allowed to travel. Fleet operators receive notifications when a vehicle enters or exits an unauthorized location and reports are generated detailing time spent in unauthorized areas. Its FleetTracking Dashboard provides fleet operators with a way to monitor overall fleet performance through a graphical summary. This interface allows fleet operators to evaluate performance categories across their fleet, including speed, engine on-time, vehicle idling, vehicle mileage and number of stops. Fleet operators can also view individual vehicle performance.

The Company provides its customers with over 40 pre-built on-demand reports, which they can access to analyze fleet data. Its reports contain information about vehicle movement and use, including vehicle location, ignition on and off time, engine idle time, arrival and departure times, distance traveled, hours worked, and vehicle speed. Its Mobile App is a portable software application, which fleet operators can use to access actionable business intelligence and insights over mobile devices. It includes the FleetTracking Dashboard, Reports, Tracking Alerts, Route Replay, and Geofencing and Landmarks.

With the Company�� Speed Limits feature, the Company provides a range of speed limit information across all types of roads and geographies, including local and residential roads. Speed limit is powered by FleetMatics RoadSpeed, a specialized database of average speed values derived from billions of points of vehicle movement. Its panoramic reporting engine features in-depth historical trending analyses and strategic comparative information from the customers, such as driver and organizational performance benchmarking. Its Fuel Card Reporting Integration feature integrates customers��fuel card usage information into its fleet management software platform. It provides its customers with an on-demand fue! l usage s! ummary for an entire fleet, as well as detailed information on individual vehicles. Reports are generated, which compare fuel purchases with vehicle location data.

The Company has partnered with an independent global fleet card provider to deliver a Universal Platinum MasterCard. Its Navigation Unit Integration features with Garmin global positioning system (GPS) navigation devices, streamlines dispatching and communication by integrating its fleet management software with its customers��GPS navigation devices. It provides customers with turn-by-turn directions, notification of job status, estimated time of arrival to the next job site, and easy-to-use messaging capabilities. Drivers receive automatic job updates, eliminating the need to manually enter addresses while driving. It offers customers the choice of two fleet management branded solutions, FleetMatics and SageQuest.

Advisors' Opinion:

• [By Tom Taulli]

  CSOD stock is currently trading at a fair valuation for cloud companies, with a price-to-sales ratio of 9.

  Cloud Companies to Buy: Fleetmatics (FLTX)

  When it comes to cloud companies, Fleetmatics (FLTX) stock is downright cheap. The stock trades at only five times sales, and the forward price-to-earnings ratio is 24.

• [By John Udovich]

  On Wednesday, small cap FleetMatics Group PLC (NYSE: FLTX) sank 7.99% to $32.80 and shares have been in a sort of freefall for the past few weeks after outperforming the First Trust ISE Cloud Computing Index (NASDAQ: SKYY) last summer. So what is going on and should you be investing or shorting this small cap?

• [By Louis Navellier]

  Fleetmatics Group (FLTX) is another Europe stock with the characteristics needed to be a leader in the European markets this year. The company makes software that allows operators of commercial vehicle fleets to track vehicles and learn about vehicle location, fuel usage, speed and mileage. The Irish company has seen earnings explode this year with growth of more than 700% in bottom-line profit increases.

• [By James Oberweis]

  Fleetmatics (FLTX) is a leading global provider of fleet management solutions, delivered as SaaS.

  Its mobile software platform provides fleet operators with visibility into vehicle location, fuel usage, speed, and mileage, enabling them to reduce operating and capital costs, as well as increase revenue.

Top 10 Promising Stocks To Buy Right Now: Globe Specialty Metals Inc.(GSM)

Globe Specialty Metals, Inc., together with its subsidiaries, produces and sells silicon metal and silicon-based alloys in North America, Europe, South America, and Asia. The company primarily offers silicon metal that is used as a raw material for silicone compounds, aluminum, and polysilicon. It also produces silicon-based alloys, such as ferrosilicon; magnesium-ferrosilicon-based alloys known as nodularizers; ferrosilicon-based alloys known as inoculants; calcium silicon alloys; and cored-wire silicon-based alloy products, as well as carbon electrodes, silica fume, and fines. The silicon-based alloy products are used as raw materials for steel, automotive components, and ductile iron. In addition, the company processes and supplies specialty metallurgical coal to other silicon and silicon-based alloy producers. Its customers include silicone chemical, aluminum, and steel manufacturers; auto companies and their suppliers; ductile iron foundries; manufacturers of photovol taic solar cells and computer chips; and concrete producers. The company was formerly known as International Metal Enterprises, Inc. and changed its name to Globe Specialty Metals, Inc. in November 2006. Globe Specialty Metals, Inc. was incorporated in 2004 and is headquartered in New York, New York.

Advisors' Opinion:

• [By Marc Bastow]

  Silicon metals and alloys producer Globe Specialty Metals (GSM) raised its quarterly dividend 7.1% to 7.5 cents per share, payable March 12 to shareholders of record as of Feb. 26.
  GSM Dividend Yield: 1.65%

Top 10 Promising Stocks To Buy Right Now: SciClone Pharmaceuticals Inc.(SCLN)

SciClone Pharmaceuticals, Inc. engages in the development and commercialization of novel therapeutics for the treatment of oncology, infectious diseases, cardiovascular, urological, respiratory, and central nervous system disorders in the People?s Republic of China and internationally. Its principal product is ZADAXIN for the treatment of hepatitis B and hepatitis C viruses, and certain cancers, as well as for use as a vaccine adjuvant or as a chemotherapy adjuvant for cancer patients with weakened immune systems. ZADAXIN has approval in approximately 30 countries, primarily China, the Pacific Rim, Latin America, eastern Europe, and the Middle East. The company markets and sells ZADAXIN principally through its distributors. It is also developing SCV-07, which is in Phase 2 clinical trials for the treatment of oral mucositis and hepatitis C virus. In addition, the company markets partnered products in China, including Depakine, an anti-convulsant; Tritace, an ACE inhibitor for the treatment of hypertension; Stilnox, a hypnotic for the short-term treatment of insomnia; and Aggrastat, a cardiology product. SciClone Pharmaceuticals also has commercialization rights for DC Bead, a product candidate for the treatment of advanced liver cancer in China, as well as for ondansetron RapidFilm, an oral thin film formulation of ondansetron to treat and prevent nausea and vomiting caused by chemotherapy, radiotherapy, and surgery in China and Vietnam. The company was founded in 1989 and is headquartered in Foster City, California.

Advisors' Opinion:

• [By Eric Volkman]

  SciClone (NASDAQ: SCLN  ) has a new man leading its finance team. The company announced that it hired Wilson Cheung to be its new CFO. Cheung is a longtime executive who most recently served as chief compliance officer, Asia Pacific, at digital marketing agency Velti, following a stint as that company's CFO. Before that, he was CFO and corporate secretary at AXT (NASDAQ: AXTI  ) and served in various managerial positions in firms such as KPMG and Yahoo!

• [By Monica Gerson]

  SciClone Pharmaceuticals (NASDAQ: SCLN) is expected to report its Q4 earnings at $0.15 per share on revenue of $38.30 million.

  Essex Rental (NASDAQ: ESSX) is projected to post a Q4 loss at $0.10 per share on revenue of $22.55 million.

Top 10 Promising Stocks To Buy Right Now: Western Alliance Bancorporation (WAL)

Western Alliance Bancorporation (WAL) is a bank holding company. The Company provides full-service banking and lending to locally owned businesses, professional firms, real estate developers and investors, local non-profit organizations, high net worth individuals and other consumers through its three wholly owned subsidiary banks (the Banks): Bank of Nevada (BON), operating in Southern Nevada; Western Alliance Bank (WAB), operating in Arizona and Northern Nevada, and Torrey Pines Bank (TPB), operating in California. In addition, the Company�� non-bank subsidiaries, Shine Investment Advisory Services, Inc. (Shine) and Western Alliance Equipment Finance (WAEF), offer an array of financial products and services to small to mid-sized businesses and their proprietors, including financial planning, custody and investments, and equipment leasing nationwide. It operates in four segments: Bank of Nevada, Western Alliance Bank, Torrey Pines Bank and Other.

The Company provides a range of banking services, as well as investment advisory services, through its consolidated subsidiaries. As of December 31, 2011, WAL owned an 80% interest in Shine. As of December 31, 2011, the Company owned a 24.9% interest in Miller/Russell & Associates, Inc. (MRA), an investment advisor. MRA provides investment advisory services to individuals, foundations, retirement plans and corporations.

Lending Activities

Through the Company�� banking segments, the Company provides a variety of financial services to customers, including commercial real estate loans, construction and land development loans, commercial loans, and consumer loans. Loans to businesses consisted 89.2% of the total loan portfolio at December 31, 2011. Loans to finance the purchase or refinancing of commercial real estate (CRE) and loans to finance inventory and working capital that are additionally secured by CRE make up the majority of its loan portfolio. These CRE loans are secured by apartment buildings, professional of! fices, industrial facilities, retail centers and other commercial properties. As of December 31, 2011, 49% of its CRE loans were owner-occupied. Owner-occupied commercial real estate loans are loans secured by owner-occupied nonfarm nonresidential properties for which the primary source of repayment (more than 50%) is the cash flow from the ongoing operations and activities conducted by the borrower who owns the property. Non-owner-occupied commercial real estate loans are commercial real estate loans for which the primary source of repayment is nonaffiliated rental income associated with the collateral property.

Construction and land development loans include multi-family apartment projects, industrial/warehouse properties, office buildings, retail centers and medical facilities. Commercial and industrial loans include working capital lines of credit, inventory and accounts receivable lines, mortgage warehouse lines, equipment loans and leases, and other commercial loans. Commercial loans are primarily originated to small and medium-sized businesses in a variety of industries. Consumer loans are generally offered at a higher rate and shorter term than residential mortgages. Its consumer loans include home equity loans and lines of credit, home improvement loans, credit card loans, and personal lines of credit. As of December 31, 2011, its loan portfolio totaled $4.68 billion, or approximately 68.4% of its total assets.

Investment Activities

All of the Company�� investment securities are classified as available-for-sale (AFS) or held-to-maturity (HTM). As of December 31, 2011, the Company had an investment securities portfolio of $1.48 billion, representing approximately 21.7% of its total assets. As of December 31, 2011, its investment securities portfolio consisted of the United States Government sponsored agency securities, Municipal obligations, Adjustable-rate preferred stock, Mutual funds, Corporate bonds, Direct the United States obligation and government-! sponsored! enterprise (GSE) residential mortgage-backed securities, private label residential mortgage-backed securities, Community Reinvestment Act (CRA) investments, Trust preferred securities, Private label commercial mortgage-backed securities, and Collateralized debt obligations.

Sources of Funds

The Company offers a variety of deposit products, including checking accounts, savings accounts, money market accounts and other types of deposit accounts, including fixed-rate, fixed maturity retail certificates of deposit. As of December 31, 2011, the deposit portfolio consisted of 27.5% non-interest bearing deposits and 72.5% interest-bearing deposits. Non-interest bearing deposits consist of non-interest bearing checking account balances. In addition to its deposit base, it has access to other sources of funding, including Federal Home Loan Bank (FHLB) and Federal Reserve Bank (FRB) advances, repurchase agreements and unsecured lines of credit with other financial institutions.

Financial Products and Services

In addition to traditional commercial banking activities, the Company offers other financial services to customers, including Internet banking, wire transfers, electronic bill payment, lock box services, courier, and cash management services. Through Shine, a full-service financial advisory firm, the Company offers financial planning and investment management.

Advisors' Opinion:

• [By Investment Biker]

  Investment Summary: This article is on Western Alliance Bancorporation (WAL), a growth-oriented commercial lender in the Southwest. The banks looks set to improve profitability supported by economic recovery in Last Vegas, industry-leading revenue performance and operating leverage supported by expense control. The credit profile of the bank looks excellent with limited exposure to residential mortgage and well poised to grow its loan portfolio by 20% annually over the next 3 years. It is also well set on a path to credit recovery with improving fundamentals that justifies premium valuation going forward.

Top 10 Promising Stocks To Buy Right Now: Neogen Corporation(NEOG)

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide. The company?s Food Safety segment offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, drug residues, pesticide residues, and general sanitation concerns. Its products also comprise bioluminescence-based diagnostic technology for adenosine triphosphate, a chemical found in living cells. This segment offers its products primarily to food and feed producers, meat and poultry processors, seafood processors, fruit and vegetable producers, grain producers and processors, food and beverage processors, and dairies; laboratories and producers of pharmaceuticals, cosmetics, veterinary vaccines, and nutraceutical products; and various re gulatory agencies. The company?s Animal safety segment provides pharmaceuticals, rodenticides, disinfectants, vaccines, veterinary instruments, topicals and diagnostic products, and genetic testing services to the animal safety market. Its drug detection immunoassay test kits are used for the detection of abused and therapeutic drugs in farm animals and racing animals, such as horses, greyhounds, and camels; detection of drug residues in meat and meat products; and human forensic toxicology drug screening applications. This segment?s products are also used to maintain sanitary conditions and limit the potential hazards of bacteria, fungi, and viruses. In addition, it offers various products for researchers to detect biologically-active substances; and proprietary substrates for other diagnostic test kit manufacturers. The company sells its products directly, as well as through distributors and retail chains. Neogen Corporation was founded in 1981 and is headquartered in La nsing, Michigan.

Advisors' Opinion:

• [By MONEYMORNING.COM]

  And with very quick gains of 9% in BRF SA (NYSE ADR: BRFS), 5.2% in South American agricultural play Adecoagro SA (NYSE: AGRO) and 1.6% in high-tech agribusiness player Neogen Corp. (Nasdaq: NEOG), we're doing well with our plays on (pockets of) accelerating U.S. inflation.